Concurrently, S&P assigned its “A” long-term rating to Bozeman Health’s proposed $73.4 million series 2018 revenue bonds.
The downgrade is based on several factors, including Bozeman Health’s deteriorating operating performance, heavy debt burden and weaker annual debt service coverage. S&P favorably viewed Bozeman Health’s strong enterprise profile.
The outlook is stable.
More articles on healthcare finance:
UCLA Health to establish health sciences learning center with $20M gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
